Andreessen Horowitz

Juniper develops a behavioral health practice management software designed to streamline the logistical operations of clinics. The platform integrates various functions, including patient onboarding and billing, into a single cohesive system. It focuses on reducing manual tasks that clinicians typically encounter, thereby enhancing efficiency. Additionally, Juniper's software emphasizes compatibility with third-party applications, allowing for better automation and accountability across clinic operations. This holistic approach enables clinics to improve their reporting capabilities and manage their databases more effectively, ultimately supporting their growth and operational scalability.

Echo Neurotechnologies is a company that specializes in the development of brain-machine interfaces. These interfaces allow patients to control external devices using only their thoughts, restoring a degree of independence and communication to those with severe disabilities. The company's primary focus is on creating neuroscience products that can significantly improve the quality of life for its users.

Counsel Health helps patients to get access to medical advice virtually.

Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy to expand access for patients, improve health outcomes, and increase the financial impact of a clinic's pharmacy program.

Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.

GC Therapeutics is a biotechnology company focused on the programming of patient-derived stem cells into various cell types using synthetic biology. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, allowing for efficient and scalable cell programming. Their technology enables the creation of customized cells, known as SuperCells™, tailored for specific medical conditions. With a foundation rooted in research from Professor George Church's lab at Harvard Medical School, GC Therapeutics aims to streamline the manufacturing process of unique cell therapies while enhancing cell quality and efficiency. The company is composed of a team of biologists and tissue engineers committed to advancing this innovative approach to improve patient outcomes.

IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing precision combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms and enhance the duration of therapeutic responses. Through its innovative approach, IDRx aims to transform cancer treatment by enabling healthcare professionals to create targeted cancer medicines tailored to individual patient needs.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Thyme Care is a healthcare company specializing in oncology care management services. It provides an integrated oncology solution that connects patients and providers, partnering with health plans to deliver comprehensive support for cancer patients. Thyme Care aims to transform cancer care by offering personalized and holistic assistance tailored to the unique needs of each patient. Its platform features physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. By employing a tech-enabled model, Thyme Care generates actionable insights that help healthcare providers identify at-risk patients earlier, ensuring timely access to quality resources and enhancing the overall cancer care experience through early and ongoing intervention.

Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

Santa Ana Bio is a biotechnology company focused on developing precision biologics for autoimmune and inflammatory diseases. The company employs advanced technologies, including deep cell profiling, multi-omics platforms, and single-cell genomics, to create targeted therapies. By utilizing antibody engineering and sophisticated analytics, Santa Ana Bio aims to deliver personalized treatments that enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

Elegen is a biotechnology company founded in 2017 and led by Dr. Matthew Hill, specializing in the development of microfluidic technology. The company focuses on creating innovative DNA synthesizers that enhance the engineering of entire genomes. By leveraging its advanced technology, Elegen aims to accelerate biomedical advancements and facilitate DNA sequence testing within the healthcare industry. Through its commitment to disrupting synthetic biology, Elegen is positioned to play a pivotal role in the future of genetic research and applications.

Milu Health is a healthcare platform focused on simplifying and reducing the costs associated with medical care for employees. By leveraging electronic health records, claims, and pricing data, the company identifies cost-saving opportunities in healthcare. Milu Health provides price transparency data that helps users find high-quality, reasonably-priced doctors and hospitals for common procedures and surgeries. This enables patients to make informed decisions regarding their healthcare, ultimately leading to savings on doctor visits, procedures, prescription drugs, and medical bills.

Ambience Healthcare is a developer of an advanced artificial intelligence-powered medical scribe that aims to enhance clinician efficiency and alleviate burnout. Its Ambience AI operating system features a suite of synergistic applications designed to capture the nuances of clinician-patient conversations in real-time, generating comprehensive notes that integrate seamlessly into electronic medical record workflows. The system employs state-of-the-art speech recognition and custom-built AI to produce documentation in seconds while accommodating individual clinician preferences to reflect their unique style and voice. By utilizing Ambience's technology, healthcare systems can significantly reduce documentation time by an average of 78%, improve coding integrity, and achieve substantial returns on investment, ultimately enabling clinicians to close all their charts by the end of their shifts and achieve a better work-life balance.

Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage and receive timely notifications for recertification and renewal. This streamlined approach helps reduce care gaps and ensures clients are enrolled in the most suitable medical plan programs.

Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.

Mana.bio is an AI-based drug delivery company specializing in gene therapy, particularly in the development of DNA and RNA-based therapeutics and vaccines. The firm utilizes machine learning and nanotechnology to enhance the formulation of lipid nanoparticle systems, which are essential for oligonucleotide therapies. By integrating advanced technologies, Mana.bio aims to improve drug delivery services within the healthcare industry, facilitating more effective treatment options.

Inceptive is a biotechnology company that specializes in designing RNA molecules through the integration of large-scale deep learning and high-throughput experimental methods. The company focuses on creating innovative biological software tools that facilitate the rational design of novel medicines and biotechnologies. By enabling the development of synthetic molecules for complex biological functions, Inceptive aims to advance healthcare and biotechnological solutions that were previously beyond reach, thus positioning itself at the forefront of medical and scientific innovation.

Thyme Care is a healthcare company specializing in oncology care management services. It provides an integrated oncology solution that connects patients and providers, partnering with health plans to deliver comprehensive support for cancer patients. Thyme Care aims to transform cancer care by offering personalized and holistic assistance tailored to the unique needs of each patient. Its platform features physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. By employing a tech-enabled model, Thyme Care generates actionable insights that help healthcare providers identify at-risk patients earlier, ensuring timely access to quality resources and enhancing the overall cancer care experience through early and ongoing intervention.

Genesis Therapeutics Inc. is a biotechnology company focused on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019 and headquartered in South San Francisco, California, the company utilizes a proprietary artificial intelligence platform that integrates deep neural networks, biophysical simulation techniques, and scalable computing infrastructure. This innovative approach enhances the efficiency and accuracy of drug discovery and molecular design, allowing for improved molecular generation and property prediction. By leveraging these advanced technologies, Genesis Therapeutics seeks to transform the drug development process, ultimately aiming to optimize clinical outcomes for patients in need of effective therapies.

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

Function Oncology is a precision medicine company focused on transforming cancer treatment through its innovative CRISPR-powered personalized functional genomics platform. This platform enables the identification of therapeutic opportunities tailored to individual patients, allowing for a deeper understanding of cancer at a patient-specific level. By leveraging advanced genomic techniques, Function Oncology aims to develop targeted cancer therapies that address the unique characteristics of each patient's disease, ultimately advancing the future of cancer care.

Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Pearl Health is a healthcare technology company founded in 2020 that focuses on empowering primary care providers and organizations to enhance patient care and optimize financial performance within value-based care models. The company offers a care-delivery and billing platform that simplifies administrative burdens for physicians, allowing them to concentrate on patient care. Pearl Health provides a fixed per-member-per-month payment structure for traditional members, along with clinical insights through analytics and performance optimization services. By partnering with thousands of primary care providers across 44 states, Pearl aims to improve healthcare quality, lower overall costs, and reward providers for keeping patients healthy. The company's team comprises physicians, public health experts, technologists, and risk management professionals who are committed to addressing significant challenges in the healthcare system.

Firefly Health, Inc. is a healthcare company based in Wellesley, Massachusetts, founded in 2016. It specializes in providing primary health care services through an artificial intelligence-based platform that connects patients with healthcare professionals. The company focuses on a virtual-first primary care approach, allowing users to access live video appointments with primary care physicians and care teams. This model emphasizes convenience and accessibility without membership fees, enabling patients to make informed decisions about their health. Firefly Health aims to redefine patient care by blending advanced technology with a dedicated care team to ensure continuous and proactive support for common health conditions, including back pain, stomach flu, and women's health issues.

Revero is an online clinic established in 2019 and based in San Francisco, California, that focuses on treating chronic conditions through a root-cause approach. The company offers personalized treatments for autoimmune and metabolic conditions, primarily utilizing nutrition therapy and remote medical care. Revero's platform integrates clinical expertise with machine learning and digital tools, allowing patients to track their historical progress and receive feedback on their health journey. The primary objective of Revero is to assist patients in lowering blood sugar, enhancing metabolic health, reducing inflammation, and restoring gut health.

Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing precision combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms and enhance the duration of therapeutic responses. Through its innovative approach, IDRx aims to transform cancer treatment by enabling healthcare professionals to create targeted cancer medicines tailored to individual patient needs.

Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company aims to revolutionize cancer immunotherapies by identifying the safest and most effective targets for treatment. Utilizing a platform-based cell therapy approach, Cartography employs single-cell analysis to discover novel CAR-T targets. This methodology empowers clients to enhance their molecular biology and computational methods, facilitating the advancement of innovative cancer immunotherapies. By prioritizing precision and safety, Cartography Biosciences is dedicated to transforming the landscape of cancer treatment.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

Topography Health is a company that facilitates the participation of private practice physicians in clinical trials, thereby advancing medical research. It provides a comprehensive platform that assists medical practices in understanding their patient populations and identifying studies that are likely to be accepted and impactful. The company also aids in recruiting patients and managing research staff, effectively addressing the barriers that physicians often face when entering the research field. By enabling local clinical trials, Topography Health offers patients with diverse health conditions access to personalized medical research opportunities for the first time.

Nitra is a financial technology company focused on transforming the healthcare industry through innovative and efficient solutions. It provides a suite of machine learning-powered financial software that includes credit cards, loans, accounts, payments, and expense management tools specifically designed for medical professionals. Nitra's platform enables healthcare providers to streamline their financial operations, allowing them to balance patient care with practice management. Its offerings include a business card that rewards spending and fosters partnerships with various service providers, as well as user-friendly accounting and receipt reconciliation tools. Nitra is committed to equipping the healthcare sector with advanced technology and dedicated support, ensuring that financial management can be both effective and straightforward.

Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.

Elegen is a biotechnology company founded in 2017 and led by Dr. Matthew Hill, specializing in the development of microfluidic technology. The company focuses on creating innovative DNA synthesizers that enhance the engineering of entire genomes. By leveraging its advanced technology, Elegen aims to accelerate biomedical advancements and facilitate DNA sequence testing within the healthcare industry. Through its commitment to disrupting synthetic biology, Elegen is positioned to play a pivotal role in the future of genetic research and applications.

Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.

Thyme Care is a healthcare company specializing in oncology care management services. It provides an integrated oncology solution that connects patients and providers, partnering with health plans to deliver comprehensive support for cancer patients. Thyme Care aims to transform cancer care by offering personalized and holistic assistance tailored to the unique needs of each patient. Its platform features physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. By employing a tech-enabled model, Thyme Care generates actionable insights that help healthcare providers identify at-risk patients earlier, ensuring timely access to quality resources and enhancing the overall cancer care experience through early and ongoing intervention.

Pearl Health is a healthcare technology company founded in 2020 that focuses on empowering primary care providers and organizations to enhance patient care and optimize financial performance within value-based care models. The company offers a care-delivery and billing platform that simplifies administrative burdens for physicians, allowing them to concentrate on patient care. Pearl Health provides a fixed per-member-per-month payment structure for traditional members, along with clinical insights through analytics and performance optimization services. By partnering with thousands of primary care providers across 44 states, Pearl aims to improve healthcare quality, lower overall costs, and reward providers for keeping patients healthy. The company's team comprises physicians, public health experts, technologists, and risk management professionals who are committed to addressing significant challenges in the healthcare system.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.

Bayesian Health Inc. is a digital health company headquartered in New York, New York, that specializes in developing an AI-driven platform designed to enhance patient care within hospital settings. The platform integrates with electronic medical records (EMR) systems to provide real-time data and actionable insights, allowing clinical staff and hospital leadership to monitor illness severity and detect changes in patient acuity. By leveraging artificial intelligence and machine learning, Bayesian Health's technology supports healthcare providers in making informed, data-driven decisions, thereby improving the efficiency and safety of patient care. Established in 2016, the company aims to optimize decision-making processes in complex clinical environments, ultimately increasing the capacity of frontline healthcare teams.

Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Nautilus Biotechnology Inc. is a development stage life sciences company focused on advancing proteomics to enhance therapeutic development and medical diagnostics. The company aims to create a platform technology that quantifies and unlocks the complexity of the human proteome, ultimately facilitating personalized and predictive medicine. Nautilus has developed a prototype of its innovative single-molecule instrument, the Proteomic Analysis System, which is designed to address challenges in protein analysis that have previously hindered progress in the field. The diverse expertise of its team, which includes professionals from various scientific disciplines such as protein chemistry, molecular biology, and bioinformatics, positions Nautilus to significantly impact drug development and improve human health management.

Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing adeno-associated virus (AAV) vectors for gene therapy applications. Its innovative platform utilizes artificial intelligence, next-generation DNA synthesis, and high-throughput sequencing to design and optimize AAV capsids, which are crucial for delivering therapeutic genes effectively and safely. By leveraging machine learning and quantitative experimentation, Dyno Therapeutics aims to revolutionize the design of gene vectors, focusing on enhancing cell-targeting capabilities. The company's approach seeks to advance the field of gene therapy, making it possible for researchers to access novel AAV vectors that can facilitate more efficient in vivo delivery of new treatments.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.

Firefly Health, Inc. is a healthcare company based in Wellesley, Massachusetts, founded in 2016. It specializes in providing primary health care services through an artificial intelligence-based platform that connects patients with healthcare professionals. The company focuses on a virtual-first primary care approach, allowing users to access live video appointments with primary care physicians and care teams. This model emphasizes convenience and accessibility without membership fees, enabling patients to make informed decisions about their health. Firefly Health aims to redefine patient care by blending advanced technology with a dedicated care team to ensure continuous and proactive support for common health conditions, including back pain, stomach flu, and women's health issues.

Scribe Therapeutics Inc. is a biotechnology company focused on developing innovative therapies utilizing engineered CRISPR technologies to address genetic disorders. Founded in 2018 and based in Berkeley, California, Scribe Therapeutics is known for its proprietary X-Editing (XE) molecules, which are advanced CRISPR enzymes designed to enhance efficacy, specificity, and deliverability compared to existing genome editing methods. The company's platform aims to overcome the limitations of current technologies by creating custom-engineered enzymes and delivery systems that facilitate precise genetic modifications. Scribe Therapeutics is committed to establishing CRISPR-based therapies as a new standard of clinical care, with the potential to significantly impact the treatment landscape for a variety of diseases, including those related to immuno-oncology, degenerative disorders, and enzyme replacement therapy.

Biodock is a developer of a cloud-based analysis platform that specializes in the analysis and storage of biological data, particularly microscopy images. Its innovative technology automates what traditionally takes months of analysis into just minutes, leveraging an end-to-end AI architecture. The platform offers auto-scaling storage and GPU compute capabilities, resulting in analysis that is 30-50% more accurate. Designed with scientists in mind, it provides a user-friendly interface that enables clinicians to efficiently upload, analyze, and download data at a single-cell level, complete with publication-ready graphs. Additionally, Biodock processes millions of cells weekly for its academic and enterprise customers, contributing to the creation of a vast image dataset that enhances its competitive edge in the market.

Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.

Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

BioAge Labs, Inc. is a biotechnology company focused on developing therapies to treat aging and age-related diseases. The company utilizes a proprietary systems biology and artificial intelligence platform to identify significant drug targets that influence aging, leveraging extensive datasets to uncover the molecular drivers of age-related pathologies. Among its key offerings is BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor that activates HIF-1 target genes involved in various biological processes, including tissue regeneration and vascular remodeling. Another notable product is BGE-175, an orally administered inhibitor targeting the prostaglandin D2 DP1 signaling pathway, which is linked to an increased risk of mortality and infections, including those associated with immune aging. Founded in 2015 and headquartered in Richmond, California, BioAge Labs is dedicated to harnessing the biology of human aging to create innovative therapies for metabolic and age-related diseases.

Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Nautilus Biotechnology Inc. is a development stage life sciences company focused on advancing proteomics to enhance therapeutic development and medical diagnostics. The company aims to create a platform technology that quantifies and unlocks the complexity of the human proteome, ultimately facilitating personalized and predictive medicine. Nautilus has developed a prototype of its innovative single-molecule instrument, the Proteomic Analysis System, which is designed to address challenges in protein analysis that have previously hindered progress in the field. The diverse expertise of its team, which includes professionals from various scientific disciplines such as protein chemistry, molecular biology, and bioinformatics, positions Nautilus to significantly impact drug development and improve human health management.

Topography Health is a company that facilitates the participation of private practice physicians in clinical trials, thereby advancing medical research. It provides a comprehensive platform that assists medical practices in understanding their patient populations and identifying studies that are likely to be accepted and impactful. The company also aids in recruiting patients and managing research staff, effectively addressing the barriers that physicians often face when entering the research field. By enabling local clinical trials, Topography Health offers patients with diverse health conditions access to personalized medical research opportunities for the first time.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, the company focuses on streamlining access to a wide range of products, including wheelchairs, walkers, ventilators, prosthetics, orthotics, and various other medical supplies. Tomorrow Health connects patients with medical equipment suppliers based on factors such as insurance coverage and geographic location, ensuring that individuals and families can efficiently obtain the necessary care in their homes. By simplifying the ordering process and coordinating logistics, the company aims to eliminate cumbersome paperwork and reduce delivery delays, thereby enhancing the overall experience for patients managing their healthcare needs.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.

Genesis Therapeutics Inc. is a biotechnology company focused on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019 and headquartered in South San Francisco, California, the company utilizes a proprietary artificial intelligence platform that integrates deep neural networks, biophysical simulation techniques, and scalable computing infrastructure. This innovative approach enhances the efficiency and accuracy of drug discovery and molecular design, allowing for improved molecular generation and property prediction. By leveraging these advanced technologies, Genesis Therapeutics seeks to transform the drug development process, ultimately aiming to optimize clinical outcomes for patients in need of effective therapies.

Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.

Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

BioAge Labs, Inc. is a biotechnology company focused on developing therapies to treat aging and age-related diseases. The company utilizes a proprietary systems biology and artificial intelligence platform to identify significant drug targets that influence aging, leveraging extensive datasets to uncover the molecular drivers of age-related pathologies. Among its key offerings is BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor that activates HIF-1 target genes involved in various biological processes, including tissue regeneration and vascular remodeling. Another notable product is BGE-175, an orally administered inhibitor targeting the prostaglandin D2 DP1 signaling pathway, which is linked to an increased risk of mortality and infections, including those associated with immune aging. Founded in 2015 and headquartered in Richmond, California, BioAge Labs is dedicated to harnessing the biology of human aging to create innovative therapies for metabolic and age-related diseases.

Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Scribe Therapeutics Inc. is a biotechnology company focused on developing innovative therapies utilizing engineered CRISPR technologies to address genetic disorders. Founded in 2018 and based in Berkeley, California, Scribe Therapeutics is known for its proprietary X-Editing (XE) molecules, which are advanced CRISPR enzymes designed to enhance efficacy, specificity, and deliverability compared to existing genome editing methods. The company's platform aims to overcome the limitations of current technologies by creating custom-engineered enzymes and delivery systems that facilitate precise genetic modifications. Scribe Therapeutics is committed to establishing CRISPR-based therapies as a new standard of clinical care, with the potential to significantly impact the treatment landscape for a variety of diseases, including those related to immuno-oncology, degenerative disorders, and enzyme replacement therapy.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

BioAge Labs, Inc. is a biotechnology company focused on developing therapies to treat aging and age-related diseases. The company utilizes a proprietary systems biology and artificial intelligence platform to identify significant drug targets that influence aging, leveraging extensive datasets to uncover the molecular drivers of age-related pathologies. Among its key offerings is BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor that activates HIF-1 target genes involved in various biological processes, including tissue regeneration and vascular remodeling. Another notable product is BGE-175, an orally administered inhibitor targeting the prostaglandin D2 DP1 signaling pathway, which is linked to an increased risk of mortality and infections, including those associated with immune aging. Founded in 2015 and headquartered in Richmond, California, BioAge Labs is dedicated to harnessing the biology of human aging to create innovative therapies for metabolic and age-related diseases.

Shield Bio is a biotechnology company focused on combating antibiotic resistance, a growing public health crisis projected to surpass cancer-related deaths by 2050. The company has developed a novel genomic testing platform that enables sexually transmitted infection (STI) clinics to accurately identify antibiotic-resistant strains of pathogens, particularly gonorrhea, which has shown resistance to multiple antibiotics. With approximately 820,000 new gonorrhea infections annually in the United States and the Centers for Disease Control and Prevention designating resistant strains as an urgent threat, Shield Bio's rapid and precise molecular antibiotic susceptibility testing is critical. This platform allows healthcare providers to determine the most effective antibiotics for treatment, thereby enhancing patient outcomes and helping to curb the spread of antibiotic resistance.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Jungla Inc., established in 2016 and headquartered in South San Francisco, is a biotechnology company specializing in molecular function software for healthcare and pharmaceutical industries. It optimizes disease diagnosis by developing advanced functional genomics, computational biophysics, and computer science technologies. Jungla's platform proactively assesses genetic variant risks, providing quantitative insights to complement observational data. This enhances clinical genetic testing accuracy and delivers robust, scalable results. As of July 2019, Jungla operates as a subsidiary of Invitae Corporation.

Cardiogram, Inc. is a San Francisco-based company founded in 2015 that specializes in developing a wearable device for monitoring heart health. The company's application allows users to analyze and visualize their heart rate measurements, tracking responses to various activities such as exercise, stress, and dietary changes. By detecting heartbeats and monitoring sleep and fitness patterns, Cardiogram aims to empower users to prevent serious cardiovascular issues, including strokes. The application is compatible with devices equipped with heart rate monitors, such as the Apple Watch and Android Wear, and facilitates the sharing of heart rate data through various social media platforms.

Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Human API is a health data network that facilitates the real-time sharing and viewing of health information across various platforms. Founded in 2013 and headquartered in San Mateo, California, the company connects consumers with their health data from a wide range of sources, including 90% of US hospitals, electronic medical records, pharmacies, labs, and over 300 wearable devices and wellness applications. The platform utilizes a machine learning-powered data pipeline to structure health data into a consistent format, making it accessible for medical researchers and scientists. Importantly, Human API empowers consumers by giving them full control over the sharing of their health information, while also providing companies with a streamlined method to access fragmented health data.

SolveBio is a contextual knowledge hub that specializes in genomic intelligence, aimed at supporting pharmaceutical, biotechnology, and diagnostic organizations. The company offers a platform designed to manage, distribute, and access genomic reference data at scale, facilitating the integration of both external and internal genomic information. This platform enables clients to leverage valuable third-party data assets, thereby driving innovation in precision medicine and advancing human health. By providing a real-time dynamic interface, SolveBio empowers organizations to effectively utilize genomic information in their research and development efforts.

Human API is a health data network that facilitates the real-time sharing and viewing of health information across various platforms. Founded in 2013 and headquartered in San Mateo, California, the company connects consumers with their health data from a wide range of sources, including 90% of US hospitals, electronic medical records, pharmacies, labs, and over 300 wearable devices and wellness applications. The platform utilizes a machine learning-powered data pipeline to structure health data into a consistent format, making it accessible for medical researchers and scientists. Importantly, Human API empowers consumers by giving them full control over the sharing of their health information, while also providing companies with a streamlined method to access fragmented health data.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.